Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/169199
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Peñalver, Francisco-Javier | - |
dc.contributor.author | Sancho, Juan Manuel | - |
dc.contributor.author | Fuente, Adolfo de la | - |
dc.contributor.author | Olave, María-Teresa | - |
dc.contributor.author | Martín, Alejandro | - |
dc.contributor.author | Panizo, Carlos | - |
dc.contributor.author | Pérez-Ceballos, Elena | - |
dc.contributor.author | Salar, Antonio | - |
dc.contributor.author | Orfao, Alberto | - |
dc.date.accessioned | 2018-08-28T09:28:28Z | - |
dc.date.available | 2018-08-28T09:28:28Z | - |
dc.date.issued | 2017 | - |
dc.identifier | doi: 10.3324/haematol.2016.149120 | - |
dc.identifier | e-issn: 1592-8721 | - |
dc.identifier | issn: 0390-6078 | - |
dc.identifier.citation | Haematologica 102(2): 235-245 (2017) | - |
dc.identifier.uri | http://hdl.handle.net/10261/169199 | - |
dc.description.abstract | Diffuse large B-cell lymphoma patients have a 5% overall risk of central nervous system events (relapse or progression), which account for high morbidity and frequently fatal outcomes,1 and shortened overall survival of <6 months.2 Early diagnosis of central nervous system events is critical for successful treatment and improved prognosis. Identification of patients at risk of central nervous system disease is critical to accurately identify candidates for central nervous system prophylaxis vs. therapy. This report by the Spanish Lymphoma Group (GELTAMO) aims to provide useful guidelines and recommendations for the prevention, diagnosis, and treatment of central nervous system diffuse large B-cell lymphoma patients with, or at risk of, leptomeningeal and/or brain parenchyma lymphoma relapse. A panel of lymphoma experts working on behalf of GELTAMO reviewed all data published on these topics available in PubMed up to May 2016. Recommendations were classified according to the Grading of Recommendations Assessment Development and Evaluation (GRADE) approach.6 A practical algorithm based on the proposed recommendations was then developed (Figure 1). Initial discussions among experts were held in May 2014, and final consensus was reached in June 2016. The final manuscript was reviewed by all authors and the Scientific Committee of GELTAMO. | - |
dc.publisher | Ferrata Storti Foundation | - |
dc.rights | closedAccess | - |
dc.title | Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO) | - |
dc.type | artículo | - |
dc.identifier.doi | 10.3324/haematol.2016.149120 | - |
dc.date.updated | 2018-08-28T09:28:32Z | - |
dc.description.version | Peer Reviewed | - |
dc.language.rfc3066 | eng | - |
dc.relation.csic | Sí | - |
dc.identifier.pmid | 27846613 | - |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | es_ES |
item.openairetype | artículo | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | No Fulltext | - |
Aparece en las colecciones: | (IBMCC) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
20
checked on 09-abr-2024
SCOPUSTM
Citations
32
checked on 23-abr-2024
WEB OF SCIENCETM
Citations
28
checked on 25-feb-2024
Page view(s)
278
checked on 23-abr-2024
Download(s)
89
checked on 23-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Artículos relacionados:
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.